日本类风湿性关节炎患者抑郁症的成本：来自行政数据的证据。
Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data.
作者信息
Guelfucci Florent, Kaneko Yuko, Mahlich Jörg, Sruamsiri Rosarin
机构信息
Creativ-Ceutical, Paris, France.
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
出版信息
Rheumatol Ther. 2018 Jun;5(1):171-183. doi: 10.1007/s40744-018-0096-4. Epub 2018 Feb 22.
Abstract
INTRODUCTION
To determine the cost of depression comorbidity among Japanese adults with rheumatoid arthritis (RA).
METHODS
A retrospective database study of 8968 patients diagnosed with RA between 2010 and 2015 and treated with any RA medication was conducted. Health care utilization characteristics were compared between patients with and without a comorbidity of depression. Propensity score matching was applied to ensure a balanced comparison between the two cohorts.
RESULTS
The prevalence of a depression comorbidity was found for 5% of the total RA patients. This comorbidity was associated with 62% (56%) higher total outpatient visits and 66% (163%) higher rate of emergency room visits after 6 (12) months.
CONCLUSIONS
Burden of depression among RA patients in Japan is relatively high and awareness for depression as a comorbidity of RA needs to be reinforced.
FUNDING
Janssen Pharmaceutical KK.
摘要
引言
确定日本成年类风湿关节炎（RA）患者中抑郁症合并症的成本。
方法
对2010年至2015年间诊断为RA并接受任何RA药物治疗的8968例患者进行回顾性数据库研究。比较了有和没有抑郁症合并症的患者的医疗保健利用特征。应用倾向得分匹配以确保两个队列之间的平衡比较。
结果
在所有RA患者中，抑郁症合并症的患病率为5%。这种合并症与6个月（12个月）后门诊总就诊次数增加62%（56%）以及急诊就诊率增加66%（163%）相关。
结论
日本RA患者中抑郁症负担相对较高，需要加强对抑郁症作为RA合并症的认识。
资金来源
杨森制药株式会社。
相似文献
1
Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data.日本类风湿性关节炎患者抑郁症的成本：来自行政数据的证据。
Rheumatol Ther. 2018 Jun;5(1):171-183. doi: 10.1007/s40744-018-0096-4. Epub 2018 Feb 22.
2
The economic burden of depression among adults with rheumatoid arthritis in the United States.美国类风湿性关节炎成年患者抑郁症的经济负担。
J Med Econ. 2019 Apr;22(4):372-378. doi: 10.1080/13696998.2019.1572015. Epub 2019 Feb 5.
3
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.类风湿关节炎患者的疲劳或晨僵的经济负担：来自真实世界数据的回顾性分析。
Curr Med Res Opin. 2020 Jan;36(1):161-168. doi: 10.1080/03007995.2019.1658974. Epub 2019 Sep 23.
4
The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis.抗环瓜氨酸肽抗体阳性的类风湿关节炎患者的经济负担。
J Manag Care Spec Pharm. 2018 Jan;24(1):4-11. doi: 10.18553/jmcp.2017.17129. Epub 2017 Jul 17.
5
Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population-Based Study.精神共病对类风湿关节炎患者医疗利用的影响：一项基于人群的研究。
Arthritis Care Res (Hoboken). 2021 Jan;73(1):90-99. doi: 10.1002/acr.24386.
6
Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis.类风湿关节炎患者对靶向免疫调节剂应答不足的经济负担。
J Manag Care Spec Pharm. 2018 Apr;24(4):344-352. doi: 10.18553/jmcp.2018.24.4.344.
7
Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.德克萨斯州医疗补助计划中诊断为类风湿关节炎的患者使用肿瘤坏死因子抑制剂的药物疗效。
J Manag Care Spec Pharm. 2014 Jul;20(7):657-67. doi: 10.18553/jmcp.2014.20.7.657.
8
Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis.夏威夷痛风患者的医疗保健利用模式-与类风湿性关节炎相比，急诊室利用率较高。
PLoS One. 2019 Aug 15;14(8):e0220978. doi: 10.1371/journal.pone.0220978. eCollection 2019.
9
High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.基于日本健康保险数据库的一项横断面研究显示，类风湿关节炎患者心血管合并症的患病率较高。
Mod Rheumatol. 2016 Jul;26(4):522-8. doi: 10.3109/14397595.2015.1106682. Epub 2015 Dec 14.
10
Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.依那西普治疗类风湿关节炎患者后的医疗利用变化：一项回顾性理赔分析。
Adv Ther. 2017 Sep;34(9):2093-2103. doi: 10.1007/s12325-017-0596-6. Epub 2017 Aug 2.
引用本文的文献
1
Estimation of life expectancy and healthcare cost in rheumatoid arthritis patients with and without depression: a population-based retrospective cohort study.伴有和不伴有抑郁症的类风湿关节炎患者的预期寿命和医疗费用估计：一项基于人群的回顾性队列研究。
Front Med (Lausanne). 2023 Nov 2;10:1221393. doi: 10.3389/fmed.2023.1221393. eCollection 2023.
2
The Current Status and Challenges in the Diagnosis and Treatment of Rheumatoid Arthritis in China: An Annual Report of 2019.中国类风湿关节炎诊断与治疗的现状及挑战：2019年年报
Rheumatol Immunol Res. 2021 Apr 13;2(1):49-56. doi: 10.2478/rir-2021-0008. eCollection 2021 Mar.
3
Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population-Based Study.精神共病对类风湿关节炎患者医疗利用的影响：一项基于人群的研究。
Arthritis Care Res (Hoboken). 2021 Jan;73(1):90-99. doi: 10.1002/acr.24386.
4
Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New "Preference Fit" Framework for Treatment Assessment.日本类风湿性关节炎患者的共同决策与患者满意度：一种用于治疗评估的新“偏好匹配”框架
Rheumatol Ther. 2019 Jun;6(2):269-283. doi: 10.1007/s40744-019-0156-4. Epub 2019 May 2.
5
Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs.生物改善病情抗风湿药的持续使用及其相关资源利用和成本
Drugs Real World Outcomes. 2018 Sep;5(3):169-179. doi: 10.1007/s40801-018-0139-8.
6
Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: A structural equation modeling approach.日本呼吸道合胞病毒感染儿童的住院费用和住院时间：一种结构方程建模方法。
Medicine (Baltimore). 2018 Jul;97(29):e11491. doi: 10.1097/MD.0000000000011491.
7
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.日本银屑病生物治疗的持续率和医疗成本：一项使用索赔数据库的真实世界数据研究
BMC Dermatol. 2018 Jul 11;18(1):5. doi: 10.1186/s12895-018-0074-0.
本文引用的文献
1
The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan.日本类风湿关节炎患者中抑郁症的患病率被低估——来自日本全国性调查的证据。
BMC Rheumatol. 2017 Nov 28;1:5. doi: 10.1186/s41927-017-0003-6. eCollection 2017.
2
Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study.日本难治性抑郁症的患病率及医疗利用情况估计：一项回顾性索赔数据库研究
Drugs Real World Outcomes. 2018 Mar;5(1):35-43. doi: 10.1007/s40801-017-0126-5.
3
Productivity loss of Japanese patients with rheumatoid arthritis - A cross-sectional survey.日本类风湿性关节炎患者的生产力损失——一项横断面调查。
Mod Rheumatol. 2018 May;28(3):482-489. doi: 10.1080/14397595.2017.1361893. Epub 2017 Aug 29.
4
[ICD coding quality for outpatient cancer diagnoses in SHI claims data].[上海市医保报销数据中门诊癌症诊断的国际疾病分类编码质量]
Z Evid Fortbild Qual Gesundhwes. 2016 Dec;118-119:48-55. doi: 10.1016/j.zefq.2016.10.004. Epub 2016 Nov 4.
5
High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs.日本在职人群中的高危动脉粥样硬化性心血管疾病：患病率、心血管事件发生率及成本
J Atheroscler Thromb. 2015;22(12):1287-304. doi: 10.5551/jat.28852. Epub 2015 Aug 18.
6
Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data.精神分裂症患者的依从性和再住院情况：来自日本报销数据的证据
Neuropsychiatr Dis Treat. 2015 Apr 1;11:935-40. doi: 10.2147/NDT.S81677. eCollection 2015.
7
Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I).利用医疗保险协会和 IORRA 队列（I）的报销数据估计日本类风湿关节炎的患病率和当前治疗实践。
Mod Rheumatol. 2014 Jan;24(1):33-40. doi: 10.3109/14397595.2013.854059.
8
The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎患者中抑郁的患病率：一项系统评价和荟萃分析。
Rheumatology (Oxford). 2013 Dec;52(12):2136-48. doi: 10.1093/rheumatology/ket169. Epub 2013 Sep 3.
9
Major depressive disorder in patients with rheumatoid arthritis.类风湿关节炎患者中的重度抑郁症。
Mod Rheumatol. 2013 Mar;23(2):237-44. doi: 10.1007/s10165-012-0643-8. Epub 2012 May 23.
10
Depression in patients with rheumatoid arthritis: description, causes and mechanisms.类风湿关节炎患者的抑郁：描述、病因及机制
Int J Clin Rheumtol. 2011;6(6):617-623. doi: 10.2217/IJR.11.6.
Zotero 插件